1. Improved taxadiene production by optimizing DXS expression and fusing short-chain prenyltransferases.
- Author
-
He, Siqi, Bekhof, Anne-Sophie M.W., Popova, Eli Z., van Merkerk, Ronald, and Quax, Wim J.
- Subjects
- *
GENE expression , *DIMETHYLALLYLTRANSTRANSFERASE , *CHIMERIC proteins , *BACILLUS subtilis , *BIOSYNTHESIS - Abstract
This study highlights the significance of overexpressing 1-deoxy-d-xylulose-5-phosphate synthase (DXS) from the MEP (methylerythritol 4-phosphate) pathway, in addition to short-chain prenyltransferase fusions for the improved production of the diterpene, taxa-4,11-diene, the first committed intermediate in the production of anti-cancer drug paclitaxel. The results showed that the strain which has (i) the taxadiene synthase (txs) gene integrated into the genome, (ii) the MEP pathway genes overexpressed, (iii) the fpps-crtE prenyltransferases fusion protein and (iv) additional expression of 1-deoxy-d-xylulose-5-phosphate synthase (DXS), yielded the highest production of taxa-4,11-diene at 390 mg/L (26 mg/L/OD 600). This represents a thirteen-fold increase compared to the highest reported concentration in B. subtilis. The focus on additional overexpression of DXS and utilizing short-chain prenyltransferase fusions underscores their pivotal role in achieving significant titer improvements in terpene biosynthesis. [Display omitted] • Utilizing Bacillus subtilis as a cell factory for the production of taxadiene. • Additional expression of DXS from MEP pathway can boost taxadiene production. • Application of fused prenyltransferases can enhance the yield of taxadiene. • The highest taxadiene production so far in B. subtilis has been achieved. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF